Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The osmotic gradient across the blood-brain barrier (BBB) refers to the difference in osmolality (concentration of solutes) between blood plasma and brain interstitial fluid. This gradient is a key physiological force influencing water movement across the BBB, which is formed by tightly joined endothelial cells in cerebral capillaries that restrict paracellular transport of most solutes. It plays roles both under physiological conditions (fluid balance) and pathologically during events like stroke-induced edema. Therapeutically manipulating this gradient enables temporary opening of the barrier but must be done cautiously due to potential risks. Main solutes are Na+ and Cl-. Agents like mannitol are used to create an artificial gradient.
Creation of osmotic gradient to drive water movement across the blood-brain barrier; Tight junction opening via cell shrinkage.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic Gradient Across the Blood-Brain Barrier.